Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Tadashi Uwagawa"'
Autor:
Masashi Tsunematsu, Koichiro Haruki, Tomohiko Taniai, Yoshiaki Tanji, Yoshihiro Shirai, Kenei Furukawa, Tadashi Uwagawa, Shinji Onda, Mitsuru Yanagaki, Teruyuki Usuba, Yukio Nakabayashi, Tomoyoshi Okamoto, Toru Ikegami
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 3, Pp 503-511 (2023)
Abstract Aim The C‐reactive protein (CRP)‐albumin‐lymphocyte (CALLY) index is a novel inflammation‐based biomarker, which has been associated with long‐term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether
Externí odkaz:
https://doaj.org/article/97bcf3a994c84ee5815fbeced2bce8f2
Autor:
Yosuke Igarashi, Takeshi Gocho, Tomohiko Taniai, Tadashi Uwagawa, Ryoga Hamura, Yoshihiro Shirai, Jungo Yasuda, Koichiro Haruki, Kenei Furukawa, Toru Ikegami
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Undifferentiated carcinoma with osteoclast-like giant cells (UCOGCs) is a rare subtype of pancreatic cancer (PC), and its clinicopathological characteristics are still unclear. Herein, we report a case of initially unresectable UC
Externí odkaz:
https://doaj.org/article/7c9a4bc3ff594650acfb9b2a7ac0dd24
Autor:
Tadashi Uwagawa, Taro Sakamoto, Takeshi Gocho, Hiroaki Shiba, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Ryoga Hamura, Kenei Furukawa, Katsuhiko Yanaga, Toru Ikegami
Publikováno v:
PLoS ONE, Vol 17, Iss 5 (2022)
Purpose To assess the efficacy of combination chemotherapy with nafamostat mesilate, gemcitabine and S-1 for unresectable pancreatic cancer patients. Materials and methods The study was conducted as a single-arm, single center, institutional review b
Externí odkaz:
https://doaj.org/article/0ed4599c3a1845c6a50a8d91e2509a65
Autor:
Masashi Tsunematsu, Koichiro Haruki, Taro Sakamoto, Tadashi Uwagawa, Hiroaki Shiba, Katsuhiko Yanaga
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background Metastatic biliary tract cancer (BTC) has poor prognosis. Recently, patients with metastatic BTC who respond well to systemic chemotherapy can be treated by radical resection or “conversion surgery.” Case presentation A 67-yea
Externí odkaz:
https://doaj.org/article/c918d04d9d3a40738d845887d96f66f0
Autor:
Naoki Takada, Hiroshi Sugano, Yoshihiro Shirai, Nobuhiro Saito, Ryoga Hamura, Tomohiko Taniai, Tadashi Uwagawa, Katsuhiko Yanaga, Toru Ikegami, Toya Ohashi, Ken Eto
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257019 (2021)
Nuclear factor kappa B (NF-κB) is a transcriptional factor that can be activated by radiotherapy and chemotherapy. The synthetic protease inhibitor nafamostat mesilate (NM) inhibits NF-κB activity and exerts antitumor actions in various types of ca
Externí odkaz:
https://doaj.org/article/57ecd7a11fee43a397cbac4cb04ddc4f
Autor:
Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga
Publikováno v:
Cancers, Vol 11, Iss 3, p 335 (2019)
The authors would like to make a correction to their published paper [...]
Externí odkaz:
https://doaj.org/article/cd2158184dbc47ccbee1d9d2aa5842cc
Autor:
Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga
Publikováno v:
Cancers, Vol 10, Iss 10, p 386 (2018)
Neoadjuvant chemoradiotherapy followed by radical surgery is the standard treatment for patients with locally advanced low rectal cancer. However, several studies have reported that ionizing radiation (IR) activates nuclear factor kappa B (NF-κB) th
Externí odkaz:
https://doaj.org/article/f4178e7d15c5415ea20a53c5188e7367
Autor:
KYOHEI ABE, KENEI FURUKAWA, YOSHIHIRO SHIRAI, SHINJI ONDA, MASASHI TSUNEMATSU, KOICHIRO HARUKI, MUNETOSHI AKAOKA, TADASHI UWAGAWA, MICHINORI MATSUMOTO, TORU IKEGAMI
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p135-140, 6p
Autor:
HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO, TORU IKEGAMI
Publikováno v:
Anticancer Research. 43:1761-1766
Autor:
Masashi Tsunematsu, Koichiro Haruki, Tomohiko Taniai, Yoshiaki Tanji, Yoshihiro Shirai, Kenei Furukawa, Tadashi Uwagawa, Shinji Onda, Mitsuru Yanagaki, Teruyuki Usuba, Yukio Nakabayashi, Tomoyoshi Okamoto, Toru Ikegami
Publikováno v:
Annals of Gastroenterological Surgery. 7:503-511